Chinasoft Int’l Names Dr. Tang Zhenming Vice Chairman; Remuneration Committee Now Fully Independent

Bulletin Express

04/17

Chinasoft International Limited announced a leadership reshuffle effective 17 April 2026.

Vice Chairman transition • Dr. He Ning stepped down as Vice Chairman as part of a planned retirement and will remain an executive director. • Executive Director Dr. Tang Zhenming has been promoted to Vice Chairman.

Remuneration Committee update • Dr. Chen Yuhong resigned from the Remuneration Committee. • The committee now consists exclusively of independent non-executive directors: Dr. Lai Guanrong (Chairman), Prof. Mo Lai Lan, and Mr. Yeung Tak Bun J.P.

Revised Board composition Following the changes, the Board comprises: • Executive Directors: Dr. Chen Yuhong (Chairman & CEO), Dr. Tang Zhenming (Vice Chairman), Dr. He Ning • Non-Executive Directors: Dr. Zhang Yaqin, Mr. Gao Liangyu • Independent Non-Executive Directors: Dr. Lai Guanrong, Prof. Mo Lai Lan, Mr. Yeung Tak Bun J.P.

The Board expressed appreciation to Dr. He and Dr. Chen for their previous roles and welcomed Dr. Tang’s new appointment.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1187933400"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1187933400\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1187933400?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-17 21:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187933400","market":"us","top_or_hot":-1,"title":"Chinasoft Int’l Names Dr. Tang Zhenming Vice Chairman; Remuneration Committee Now Fully Independent","media":"Bulletin Express","content":"<p>Chinasoft International Limited announced a leadership reshuffle effective 17 April 2026.</p>\n<p>Vice Chairman transition  \n• Dr. He Ning stepped down as Vice Chairman as part of a planned retirement and will remain an executive director.  \n• Executive Director Dr. Tang Zhenming has been promoted to Vice Chairman.</p>\n<p>Remuneration Committee update  \n• Dr. Chen Yuhong resigned from the Remuneration Committee.  \n• The committee now consists exclusively of independent non-executive directors: Dr. Lai Guanrong (Chairman), Prof. Mo Lai Lan, and Mr. Yeung Tak Bun J.P.</p>\n<p>Revised Board composition  \nFollowing the changes, the Board comprises:  \n• Executive Directors: Dr. Chen Yuhong (Chairman & CEO), Dr. Tang Zhenming (Vice Chairman), Dr. He Ning  \n• Non-Executive Directors: Dr. Zhang Yaqin, Mr. Gao Liangyu  \n• Independent Non-Executive Directors: Dr. Lai Guanrong, Prof. Mo Lai Lan, Mr. Yeung Tak Bun J.P.</p>\n<p>The Board expressed appreciation to Dr. He and Dr. Chen for their previous roles and welcomed Dr. Tang’s new appointment.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chinasoft Int’l Names Dr. Tang Zhenming Vice Chairman; Remuneration Committee Now Fully Independent</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChinasoft Int’l Names Dr. Tang Zhenming Vice Chairman; Remuneration Committee Now Fully Independent\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-04-17 21:43</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Chinasoft International Limited announced a leadership reshuffle effective 17 April 2026.</p>\n<p>Vice Chairman transition  \n• Dr. He Ning stepped down as Vice Chairman as part of a planned retirement and will remain an executive director.  \n• Executive Director Dr. Tang Zhenming has been promoted to Vice Chairman.</p>\n<p>Remuneration Committee update  \n• Dr. Chen Yuhong resigned from the Remuneration Committee.  \n• The committee now consists exclusively of independent non-executive directors: Dr. Lai Guanrong (Chairman), Prof. Mo Lai Lan, and Mr. Yeung Tak Bun J.P.</p>\n<p>Revised Board composition  \nFollowing the changes, the Board comprises:  \n• Executive Directors: Dr. Chen Yuhong (Chairman & CEO), Dr. Tang Zhenming (Vice Chairman), Dr. He Ning  \n• Non-Executive Directors: Dr. Zhang Yaqin, Mr. Gao Liangyu  \n• Independent Non-Executive Directors: Dr. Lai Guanrong, Prof. Mo Lai Lan, Mr. Yeung Tak Bun J.P.</p>\n<p>The Board expressed appreciation to Dr. He and Dr. Chen for their previous roles and welcomed Dr. Tang’s new appointment.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00354","symbol_name":"中國軟件國際","start_time":0,"source_url":"","article_id":"1187933400","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187933400","pubTimestamp":1776433409,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Chinasoft International Limited announced a leadership reshuffle effective 17 April 2026. Vice Chairman transition   • Dr. He Ning stepped down as Vice Chairman as part of a planned retirement and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00354":"中国软件国际"},"translate_title":"中软国际任命唐振明博士为副董事长；薪酬委员会现已完全独立","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00354":1},"content_text":"Chinasoft International Limited announced a leadership reshuffle effective 17 April 2026.\nVice Chairman transition  \n• Dr. He Ning stepped down as Vice Chairman as part of a planned retirement and will remain an executive director.  \n• Executive Director Dr. Tang Zhenming has been promoted to Vice Chairman.\nRemuneration Committee update  \n• Dr. Chen Yuhong resigned from the Remuneration Committee.  \n• The committee now consists exclusively of independent non-executive directors: Dr. Lai Guanrong (Chairman), Prof. Mo Lai Lan, and Mr. Yeung Tak Bun J.P.\nRevised Board composition  \nFollowing the changes, the Board comprises:  \n• Executive Directors: Dr. Chen Yuhong (Chairman & CEO), Dr. Tang Zhenming (Vice Chairman), Dr. He Ning  \n• Non-Executive Directors: Dr. Zhang Yaqin, Mr. Gao Liangyu  \n• Independent Non-Executive Directors: Dr. Lai Guanrong, Prof. Mo Lai Lan, Mr. Yeung Tak Bun J.P.\nThe Board expressed appreciation to Dr. He and Dr. Chen for their previous roles and welcomed Dr. Tang’s new appointment.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}